SCHEMBL5832992

SCHEMBL5832992

Fc1ccc(SNCc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G1B P04054 1/20 0.49
▸ ATG4B Q9Y4P1 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ KCNH3 Q9ULD8 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ PTPN1 P18031 1/20 0.41
▸ PTPRZ1 P23471 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAOB P27338 3/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KDM1A O60341 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MAOA P21397 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ IDO1 P14902 2/20 0.39
▸ THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5790558 0.86 IDO1 (0.46) ALDH1A1KDM4EPTPN1PTPRZ1POLB
SCHEMBL28757043 0.81 HTT (0.53) ALDH1A1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL20246810 0.81 MEN1 (0.58) ALDH1A1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL20246258 0.81 L3MBTL1 (0.45) ALDH1A1KDM4EPTPN1PTPRZ1KDM1A
SCHEMBL5923870 0.78 GAA (0.50) ALDH1A1RAB9AKDM4ELMNAMAOB
SCHEMBL21033910 0.73 MEN1 (0.53) ALDH1A1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL1038941 0.73 LMNA (0.65) PLA2G1BATG4BALDH1A1RAB9AKDM4E
SCHEMBL24590598 0.70 MAPT (0.51) ALDH1A1RAB9ASMN1; SMN2KDM4EPTPN1
SCHEMBL17276237 0.70 ALDH1A1 (0.58) PLA2G1BATG4BALDH1A1RAB9ASMN1; SMN2
SCHEMBL23099746 0.70 SIGMAR1 (0.49) RAB9ANPC1KMT2ACYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7041851-B2 Fluorinated phenyl thiophenyl derivatives and their use for imaging serotonin transporters THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2006-05-09 — — US disclosed
US-20030236234-A1 Fluorinated phenyl thiophenyl derivatives and their use for imaging serotonin transporters NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR 2003-12-25 — — US disclosed
WO-2003078393-A2 FLUORINATED PHENYL THIOPHENYL DERIVATIVES AND THEIR USE FOR IMAGING SEROTONIN TRANSPORTERS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2003-09-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236234-A1 Fluorinated phenyl thiophenyl derivatives and their use for imaging serotonin transporters SLC6A4, SLCO4C1, SLC6A2 PLA2G1B 3176/4885ATG4B 1503/4885ALDH1A1 2309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback